about
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity.Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression.VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction.VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
P50
Q33976964-6B23D6D1-D3C2-4DB1-BC84-55E1D884A7FDQ35890322-F4013159-B619-494E-A0D0-6B99580010BEQ36908403-8B5341C2-42DF-463D-8FD1-91E71E685CF1Q37554494-683B5103-2F92-4BD5-81FC-AF6E71175A77Q38649483-AE752E32-6BDB-4BA2-ABAE-2A39C92A1387Q40130041-ABDB4718-9CC8-4D12-A974-57D4C6566594Q41186469-8EC80E84-9CA5-474B-9C71-279220590113Q46458268-28FFF400-9ACD-461B-9A9B-2BE2E21B5CE3Q53025494-48FD8819-72EF-442C-A629-5626B2974ECD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Manuel Picon-Ruiz
@en
Manuel Picon-Ruiz
@nl
type
label
Manuel Picon-Ruiz
@en
Manuel Picon-Ruiz
@nl
prefLabel
Manuel Picon-Ruiz
@en
Manuel Picon-Ruiz
@nl
P108
P31
P496
0000-0002-9427-0946